| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Paul Glue, Julie Courts, Andrew Gray, Tess Patterso. Influence of law changes affecting synthetic cannabinoid availability and frequency of hospital presentations: 4-year national survey. The New Zealand medical journal. vol 129. issue 1433. 2017-04-21. PMID:27349159. |
we previously reported that passage of the 2013 psychoactive substances act (psa), which limited retail availability of synthetic cannabinoids (scs), was followed by reduced numbers of presentations to one psychiatric emergency service. |
2017-04-21 |
2023-08-13 |
Not clear |
| Andrea Bileck, Franziska Ferk, Halh Al-Serori, Verena J Koller, Besnik Muqaku, Alexander Haslberger, Volker Auwärter, Christopher Gerner, Siegfried Knasmülle. Impact of a synthetic cannabinoid (CP-47,497-C8) on protein expression in human cells: evidence for induction of inflammation and DNA damage. Archives of toxicology. vol 90. issue 6. 2017-02-20. PMID:26194647. |
synthetic cannabinoids (scs) are marketed worldwide as legal surrogates for marihuana. |
2017-02-20 |
2023-08-13 |
human |
| David Mathai, Mollie Gordon, Peter Muchmore, Anu Matorin, Asim Shah, Nidal Moukadda. Paradoxical increase in synthetic cannabinoid emergency-related presentations after a citywide ban: Lessons from Houston, Texas. Bulletin of the Menninger Clinic. vol 80. issue 4. 2017-02-13. PMID:27936903. |
synthetic cannabinoids (scs) have become a major drug of abuse associated with severe hospital presentations. |
2017-02-13 |
2023-08-13 |
Not clear |
| Nadine Schaefer, Jan-Georg Wojtyniak, Mattias Kettner, Julia Schlote, Matthias W Laschke, Andreas H Ewald, Thorsten Lehr, Michael D Menger, Hans H Maurer, Peter H Schmid. Pharmacokinetics of (synthetic) cannabinoids in pigs and their relevance for clinical and forensic toxicology. Toxicology letters. vol 253. 2017-02-03. PMID:27113702. |
synthetic cannabinoids (scs) are gaining increasing importance in clinical and forensic toxicology. |
2017-02-03 |
2023-08-13 |
human |
| Yuri P Springer, Roy Gerona, Erich Scheunemann, Sarah L Shafer, Thomas Lin, Samuel D Banister, Michael P Cooper, Louisa J Castrodale, Michael Levy, Jay C Butler, Joseph B McLaughli. Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids - Anchorage, Alaska, 2015-2016. MMWR. Morbidity and mortality weekly report. vol 65. issue 40. 2017-01-11. PMID:27736839. |
in july 2015, personnel in the alaska division of public health's section of epidemiology became aware of an increase in the number of patients being treated in anchorage hospital emergency departments for adverse reactions associated with use of synthetic cannabinoids (scs). |
2017-01-11 |
2023-08-13 |
Not clear |
| Yuri P Springer, Roy Gerona, Erich Scheunemann, Sarah L Shafer, Thomas Lin, Samuel D Banister, Michael P Cooper, Louisa J Castrodale, Michael Levy, Jay C Butler, Joseph B McLaughli. Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids - Anchorage, Alaska, 2015-2016. MMWR. Morbidity and mortality weekly report. vol 65. issue 40. 2017-01-11. PMID:27736839. |
scs are a chemically diverse class of designer drugs that bind to the same cannabinoid receptors as tetrahydrocannabinol, the main psychoactive component of cannabis. |
2017-01-11 |
2023-08-13 |
Not clear |
| Marina Dronova, Evgeny Smolianitski, Ovadia Le. Electrooxidation of New Synthetic Cannabinoids: Voltammetric Determination of Drugs in Seized Street Samples and Artificial Saliva. Analytical chemistry. vol 88. issue 8. 2016-12-13. PMID:26905258. |
the electrochemical sensing of new psychoactive substances, synthetic cannabinoids (scs), commonly marketed under the trade name "spice" is explored for the first time. |
2016-12-13 |
2023-08-13 |
Not clear |
| Ziva D Coope. Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal. Current psychiatry reports. vol 18. issue 5. 2016-12-13. PMID:27074934. |
although several chemical structural classes of synthetic cannabinoids (scs) were recently classified as schedule i substances, rates of use and cases of serious toxic effects remain high. |
2016-12-13 |
2023-08-13 |
Not clear |
| Celeste M Caviness, Golfo Tzilos, Bradley J Anderson, Michael D Stei. Synthetic Cannabinoids: Use and Predictors in a Community Sample of Young Adults. Substance abuse. vol 36. issue 3. 2016-11-14. PMID:25222129. |
synthetic cannabinoids (scs) are a class of drugs of abuse with deleterious consequences. |
2016-11-14 |
2023-08-13 |
Not clear |
| Liana Fattor. Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis. Biological psychiatry. vol 79. issue 7. 2016-10-28. PMID:26970364. |
synthetic cannabinoids (scs) are among the most commonly used new psychoactive substances. |
2016-10-28 |
2023-08-13 |
Not clear |
| Bronwen B Davies, Ciena Bayard, Scott J Larson, Lucas W Zarwell, Roger A Mitchel. Retrospective Analysis of Synthetic Cannabinoid Metabolites in Urine of Individuals Suspected of Driving Impaired. Journal of analytical toxicology. vol 40. issue 2. 2016-09-26. PMID:26687103. |
identification and analysis of synthetic cannabinoids (scs) in biological specimens remains an ongoing challenge for forensic toxicologists. |
2016-09-26 |
2023-08-13 |
Not clear |
| Vineet S Gudsoorkar, Jose A Pere. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure. Methodist DeBakey cardiovascular journal. vol 11. issue 3. 2016-09-13. PMID:26634029. |
synthetic cannabinoids (scs) are herbal blends that use plant material with varying concentrations of synthetic analogues of cannabinoids. |
2016-09-13 |
2023-08-13 |
human |
| Vineet S Gudsoorkar, Jose A Pere. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure. Methodist DeBakey cardiovascular journal. vol 11. issue 3. 2016-09-13. PMID:26634029. |
we describe a case of acute kidney injury associated with use of scs and present a review of the current literature, including the history and some key pharmacologic and epidemiologic findings related to synthetic cannabinoid compounds. |
2016-09-13 |
2023-08-13 |
human |
| Sevgi Buyukbese Sars. Unusual side effect of cannabis use: acute abdomen due to duodenal perforation. International journal of emergency medicine. vol 9. issue 1. 2016-07-08. PMID:27387191. |
the chronic use of synthetic cannabinoids (scs) which has become an increasingly prevalent problem can rarely cause gastric and duodenal ulcer because of their effects on gastric secretion and emptying. |
2016-07-08 |
2023-08-13 |
Not clear |
| b' Mert Mahsuni Sevinc, Erdem Kinaci, Savas Bayrak, Aytul Hande Yardimci, Ekrem Cakar, Hasan Bekta\\xc5\\x9. Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: Chronic use of synthetic cannabinoid. World journal of gastroenterology. vol 21. issue 37. 2016-05-24. PMID:26457032.' |
addiction to synthetic cannabinoids (scs) is a growing social and health problem worldwide. |
2016-05-24 |
2023-08-13 |
Not clear |
| Samuel D Banister, Jordyn Stuart, Richard C Kevin, Amelia Edington, Mitchell Longworth, Shane M Wilkinson, Corinne Beinat, Alexandra S Buchanan, David E Hibbs, Michelle Glass, Mark Connor, Iain S McGregor, Michael Kassio. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS chemical neuroscience. vol 6. issue 8. 2016-05-18. PMID:25921407. |
although terminal fluorination of n-pentyl indole scs is sometimes known to improve cannabinoid type 1 (cb1) receptor binding affinity, little is known of the effects of fluorination on functional activity of scs. |
2016-05-18 |
2023-08-13 |
human |
| Jolanta B Zawilsk. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances. International review of neurobiology. vol 120. 2016-04-21. PMID:26070762. |
based on the spectrum of their actions on cognitive processes, mood, and behavior, "legal highs" can be classified into four basis categories: amphetamine- and ecstasy-like stimulants, synthetic cannabinoids (scs), hallucinogenic/dissociative, and opioid-like compounds. |
2016-04-21 |
2023-08-13 |
human |
| Robert J Tait, David Caldicott, David Mountain, Simon L Hill, Simon Lento. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical toxicology (Philadelphia, Pa.). vol 54. issue 1. 2016-04-11. PMID:26567470. |
synthetic cannabinoids (scs) such as "spice", "k2", etc. |
2016-04-11 |
2023-08-13 |
human |
| Adam Winstock, Michael Lynskey, Rohan Borschmann, Jon Waldro. Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample. Journal of psychopharmacology (Oxford, England). vol 29. issue 6. 2016-02-22. PMID:25759401. |
synthetic cannabinoids (scs) have become increasingly popular in recent years. |
2016-02-22 |
2023-08-13 |
Not clear |
| Verena J Koller, Franziska Ferk, Halh Al-Serori, Miroslav Mišík, Armen Nersesyan, Volker Auwärter, Tamara Grummt, Siegfried Knasmülle. Genotoxic properties of representatives of alkylindazoles and aminoalkyl-indoles which are consumed as synthetic cannabinoids. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. vol 80. 2016-01-25. PMID:25792264. |
synthetic cannabinoids (scs) cause similar effects as cannabis and are sold in herbal mixtures. |
2016-01-25 |
2023-08-13 |
human |